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Liver	 transplantation	 is	 frequently	 associated	 with	 hyperkalemia,	 especially	 after	
graft	 reperfusion.	 Dual	 hypothermic	 oxygenated	machine	 perfusion	 (DHOPE)	 re‐
duces	ischemia/reperfusion	injury	and	improves	graft	function,	compared	to	conven‐
tional	static	cold	storage	 (SCS).	We	examined	the	effect	of	DHOPE	on	ex situ and 
in vivo	 shifts	of	potassium	and	sodium.	Potassium	and	sodium	shifts	were	derived	
from	balance	measurements	in	a	preclinical	study	of	livers	that	underwent	DHOPE	
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1  | INTRODUC TION










Recently,	 end‐ischemic	 hypothermic	 (oxygenated)	 machine	
perfusion	of	donor	livers	has	been	introduced	into	clinical	practice	
as	a	new	method	of	organ	preservation.	Compared	to	SCS	alone,	
additional	 graft	 preservation	 via	 hypothermic	 (oxygenated)	 ma‐
chine	perfusion	reduces	ischemia/reperfusion	injury	of	liver	grafts	
during	 transplantation.7‐9 The perfusion fluid that is currently 
used	in	Europe	and	the	US	for	hypothermic	machine	perfusion	is	
Belzer’s	 University	 of	 Wisconsin	 (UW)	 machine	 perfusion	 solu‐
tion.	Compared	 to	UW	cold storage	 solution,	UW	machine perfu‐
sion	 solution	 contains	more	 sodium	 (100	mmol/L	 vs.	 29	mmol/L)	
and	 less	potassium	 (25	mmol/L	vs.	125	mmol/L),	 although	 this	 is	
still	much	 higher	 than	 the	 potassium	 concentration	 in	 serum.	 In	
our	 first	 clinical	 series	of	dual	hypothermic	oxygenated	machine	
perfusion	 (DHOPE)	of	donor	 livers	we	noted	 that,	 in	contrast	 to	
SCS‐preserved	 livers,	 in	 vivo	 graft	 reperfusion	 did	 not	 result	 in	
acute	hyperkalemia	and	in	fact	was	accompanied	by	hypokalemia	
in three out of ten recipients.9	 Little	 is	 known	about	cation	 (po‐
tassium	and	sodium)	shifts	in	the	liver	during	ex	situ	machine	per‐









This	 study	 consisted	 of	 two	 parts:	 a	 preclinical	 study	 (part	 A)	
using	 human	 liver	 grafts	 that	were	 declined	 for	 transplantation	
and	a	clinical	study	(part	B)	of	patients	who	received	a	DHOPE‐
preserved	 liver	 graft.	 In	 both	 preclinical	 and	 clinical	 study,	
DHOPE‐preserved	 liver	 grafts	 were	 compared	 with	 livers	 that	
were	preserved	with	SCS	alone	 (controls).	The	anonymized	data	
analysis	 in	 both	 sub‐studies	was	 performed	 in	 accordance	with	
national	 guidelines	 and	 legislation.	 The	 preclinical	 study	 proto‐
col	 was	 approved	 by	 the	 competent	 authority	 for	 organ	 dona‐
tion	 in	 the	 Netherlands,	 the	 Dutch	 Transplantation	 Foundation	
(NTS)	 and	 by	 the	 medical	 ethical	 committee	 of	 our	 institution	
(University	 Medical	 Center	 Groningen,	 record	 METc	 protocol	
2012.068).	 Ethical	 approval	 for	 the	 clinical	 study	was	 obtained	
from	the	same	medical	ethical	committee	(record	METc	protocol	











of	 intracellular	 potassium	 into	 the	 extracellular	 milieu	 during	
SCS.11,12	Likewise,	the	sodium	concentration	in	UW	cold	storage	





2.3 | Dual hypothermic oxygenated machine 
perfusion (DHOPE)
DHOPE	was	 performed	 with	 3	 to	 4L	 of	 UW	machine	 perfusion	
solution	 (potassium	 concentration	 25	mmol/L	 and	 sodium	 con‐
centration	100	mmol/L;	Bridge‐to‐Life,	Ltd.)	using	the	Liver	Assist	
device	 (Organ	 Assist,	 Groningen,	 The	 Netherlands)	 according	 to	
the	manufacturer’s	 instructions.	Before	 the	 start	of	DHOPE,	 liv‐
ers	were	flushed	during	the	back	table	procedure	with	1L	of	UW	
machine	perfusion	solution	to	flush	out	UW	cold	storage	solution.	
The	 perfusion	 fluid	was	 oxygenated	 to	 obtain	 a	 pO2	 of	 approxi‐
mately	80	kPa.	During	DHOPE,	portal	vein	perfusion	pressure	was	
set	at	4	mmHg	and	mean	arterial	perfusion	pressure	at	25	mmHg.
2.4 | Part A: preclinical study












previously.13‐15	 Prior	 to	NMP,	 all	 livers	were	 flushed	with	1L	 cold	
     |  3BURLAGE Et AL.
NaCl	0.9%	solution,	followed	by	500	mL	warm	NaCl	0.9%	solution	
to	 flush	out	UW	cold	storage	 (control	 livers)	or	UW	machine	per‐
fusion	solution	(DHOPE	livers).	Oxygenation	resulted	in	a	pO2	be‐
tween	50	and	80k	kPa.	During	NMP	perfusion	pressures	were	set	
at	 11	mmHg	 for	 the	 portal	 vein	 and	 a	mean	 of	 70	mmHg	 for	 the	
hepatic artery.







warm	 ischemia	 time	 (±5	minutes),	 and	MELD	 score	 (6‐22	 or	 ≥23).	
Livers	 were	 selected	 from	 a	 previously	 published	 clinical	 study.9 
Only	livers	preserved	in	UW	cold	storage	during	the	SCS	phase	were	
included.
All	 liver	grafts	were	 implanted	by	using	 the	piggy	back	 tech‐







2.6 | Assessment of cation concentrations and shifts
During	machine	perfusion	(either	DHOPE	or	NMP),	perfusate	sam‐
ples	were	collected	at	baseline	(prior	to	connecting	liver)	and	every	
30	minutes	 thereafter.	 During	 transplantation,	 blood	 samples	 of	
the	 recipient	 were	 collected	 from	 a	 nonheparinized	 arterial	 line:	
(a)	 prior	 to	 the	 anhepatic	phase	 (pre‐anhepatic)	 and	 (b)	 during	 the	



















2.7 | Correlation between changes in cation 








2.8 | Correlation between changes in cation 









(IQR),	 or	 as	mean	±	standard	 error	 (SE)	 as	 appropriate.	Categorical	
variables	 are	presented	 as	number	 and	percentage.	Group	 charac‐
teristics	were	compared	between	groups	using	 the	Mann‐Whitney	
U‐test	for	continuous	variables	or	the	Chi‐square	test	for	categori‐






3.1 | Part A: preclinical study
3.1.1 | Donor characteristics
Donor	 and	 preservation	 characteristics	 are	 shown	 in	 Table	1.	
There	were	no	significant	differences	between	the	two	groups	in	
donor	characteristics	such	as	donor	age,	type	of	donor,	or	donor	
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warm	 ischemia	 time	 (in	 case	 of	 donation	 after	 circulatory	 death	
[DCD]).
3.1.2 | Cation concentrations and shifts during end‐
ischemic DHOPE
During	the	first	30	minutes	of	DHOPE,	the	mean	perfusate	potas‐
sium	level	 increased	from	26.6	±	0.8	to	33.4	±	1.9	mmol/L	 (P = .03)	
and	 levels	 remained	 stable	 thereafter	 (Figure	1).	 The	 total	 hepatic	
release	of	potassium	during	2	hours	of	DHOPE	was	17	±	2	mmol.
During	the	first	30	minutes	of	DHOPE,	mean	perfusate	sodium	
level	 remained	 stable	 (102	±	7	 to	 101	±	6	mmol/L)	 (P = .91)	 but	
during	the	remainder	of	DHOPE,	 levels	decreased	from	102	±	7	to	
94	±	6	mmol/L	 (P = .06)	 (Figure	2).	 The	 total	 hepatic	 uptake	 of	 so‐
dium	during	2	hours	of	DHOPE	was	25	±	9	mmol.
3.1.3 | Cation concentrations, shifts and potassium‐




out	prior	DHOPE	 (controls),	potassium	 levels	 increased	during	 the	
first	 30	minutes	 from	 4.6	±	0.4	 to	 9.0	±	1.8	mmol/L	 (P = .04).	 Both	











(151	±	1	 to	 149	±	1	mmol/L,	 respectively;	 P = .78)	 and	 levels	 re‐
mained	to	be	stable	thereafter.	In	livers	that	underwent	NMP	with‐
out	prior	DHOPE	(controls),	sodium	levels	decreased	during	the	first	




of	 7	±	3	mmol	 of	 sodium	was	 noted.	 In	 control	 (SCS	 alone)	 livers,	
an	opposite	sodium	shift	was	noted	with	a	total	hepatic	uptake	of	
23	±	9	mmol	of	sodium.
3.1.4 | Correlation between changes in cation 




μmol/g	 vs	36	 (21‐57)	μmol/g,	 respectively	 (P = .03).	 The	 change	 in	
potassium	levels	upon	ex	situ	reperfusion	correlated	negatively	with	
ATP	 levels	 after	2	hours	of	NMP	 (P < .001).	 In	other	words,	 an	 in‐
crease	in	potassium	levels	upon	ex	situ	reperfusion	correlated	with	
low	ATP	 levels	 (Table	2).	 In	contrast,	changes	 in	sodium	levels	cor‐
related	positively	with	ATP	 levels	after	2	hours	of	NMP	 (P = .048).	
Moreover,	high	potassium	 levels	upon	ex	situ	reperfusion	strongly	
predicted	 high	 peak	 ALT	 levels	 (P < .001)	 and	 peak	 lactate	 levels	
(P < .001)	(Table	2).
TA B L E  1   Comparison of donor and preservation characteristics 
of	livers	in	the	preclinical	study	(Part	A)
DHOPE 
(n = 6) Control (n = 9) P value
Donor characteristics
Age	(y) 64	(57‐70) 62	(52‐64) .29
Sex	(male) 3	(50%) 6	(67%) .62
Type of donor .23
DCD 6	(100%) 6	(67%)
DBD 0 3	(33%)































to cold flushc 
(min)
15	(13‐23) 20	(16‐23) .49








cThe	 time	 interval	 between	 cardiac	 arrest	 and	 the	 start	 of	 aortic	 cold	
flush in the donor. 
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3.2 | Part B: clinical study
3.2.1 | Patient and donor characteristics
Patient,	donor,	and	surgical	characteristics	are	shown	 in	Table	3.	
There	were	 no	 significant	 differences	 in	 baseline	 characteristics	
or	surgical	variables	between	the	groups.	Most	 importantly,	pre‐
operative	serum	potassium	and	sodium	concentrations,	as	well	as	
intra‐operative	 blood	 loss	 and	 transfusion	 of	 packed	 red	 blood	
cells	did	not	differ	between	the	two	groups.
3.2.2 | Cation concentrations and shifts during end‐
ischemic DHOPE










3.2.3 | Cation concentrations during in vivo 
reperfusion and potassium‐related interventions
After	 in	 vivo	 graft	 reperfusion,	 blood	 potassium	 levels	 decreased	
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After	 in	 vivo	 graft	 reperfusion,	 blood	 sodium	 levels	 slightly	
increased	 in	 recipients	 of	 a	 DHOPE‐treated	 liver	 (135	±	1	 to	
137	±	1	mmol/L,	 P = .04),	 whereas	 levels	 slightly	 decreased	 in	
control	(SCS	alone)	recipients	from	138	±	2	to	137	±	2	mmol/L,	yet	
this	did	not	reach	significance	(P = .23;	Figure	4).
3.2.4 | Correlation between changes in cation 
levels and postreperfusion markers of hepatic 
viability and injury
Increased	 potassium	 levels	 (mmol/L)	 upon	 portal	 reperfusion	




3.2.5 | Correlation between changes in cation 
levels and postreperfusion syndrome
In	 vivo	 reperfusion	 of	 DHOPE‐preseved	 livers	 or	 control	 liv‐
ers,	 resulted	 in	 minimal	 changes	 in	 median	 MAP	 (Figure	5).	
Postreperfusion	syndrome	occurred	 in	zero	out	of	10	patients	 in	










Cellular	ATP −0.85 <.001 0.58 .048
Peak	ALT 0.81 <.001 −0.61 .02










TA B L E  3  Comparison	of	donor	and	recipient	characteristics	of	transplanted	livers	(Part	B)
DHOPE (n = 10) Control (n = 9) P value
Donor characteristics
Age	(y) 53	(47‐57) 55	(50‐57) .90
Sex	(male) 5	(50%) 5	(57%) .46
Type of donor 1.00
DCD 10	(100%) 9	(100%)
DBD 0 0





Age	(y) 57	(54‐62) 57	(53‐62) .12
Sex	(male) 6	(60%) 4	(44%) 1.00
MELD	score 16	(15‐22) 22	(17‐25) .12
Preservation	characteristics




Time	from	circulatory	arrest	to	cold	flush	(min)c 15	(13‐17) 17	(15‐19) .41
Surgical	variables
Estimated	blood	loss	(mL) 3600	(1763‐4875) 2700	(2200‐6600) .91
Preoperative	serum	[K+]	(mmol/L) 4.3	(4.1‐4.7) 3.9	(3.9‐4.7) .78
Preoperative	serum	[Na+]	(mmol/L) 137	(133‐141) 137	(134‐141) .28
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the	DHOPE	 group	 and	 in	 one	 out	 of	 seven	 in	 the	 control	 group	
(P = .44).	Changes	in	MAP	upon	reperfusion	did	not	correlate	with	
changes	 in	potassium	and	 sodium	 levels	 (Table	4).	Unfortunately,	
recordings	 of	 the	MAP	 and	 noradrenaline	 dose	 around	 the	 time	
of	 reperfusion	were	missing	 in	 two	 (out	 of	 nine)	 patients	 in	 the	
control	group.
During	 in	 vivo	 reperfusion	 of	 DHOPE‐preserved	 livers,	 median	
noradrenaline	requirement	increased	from	0.16	(0.14‐0.29)	μg/kg/min	 
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to	 0.24	 (0.23‐0.48)	 μg/kg/min	 (P = .02).	 In	 controls,	 median	 nor‐
adrenaline	requirement	increased	from	0.14	(0.14‐0.29)	(μg/kg/min)	
to	0.27	(0.23‐0.38)	(μg/kg/min)	upon	reperfusion,	although	did	this	
not	 reach	 significance	 (P = .08)	 (Figure	5).	 Interestingly,	 increased	
potassium levels and decreased sodium levels upon reperfusion 





















Peak	ALT 0.74 .001 −0.38 .11
Peak	lactate 0.29 .27 −0.27 .26
PT	(POD	1) 0.34 .18 −0.24 .33
Δ	MAP −0.23 .40 0.25 .33




day	 1.	 Changes	 in	 cation	 levels	 were	 also	 correlated	 with	 changes	 in	





ALT,	 alanine	 aminotransferase;	 MAP,	 mean	 arterial	 pressure;	 PT,	 pro‐
thrombin	time;	POD,	postoperative	day.
F I G U R E  5  Changes	in	intraoperative	hemodynamics	upon	reperfusion.	No	significant	changes	in	mean	arterial	pressure	(MAP)	were	
noted	after	reperfusion	of	both	DHOPE	and	control	livers	(A)	while	noradrenaline	requirements	increased	in	both	groups	(B).	Increased	
noradrenaline	dose	upon	reperfusion	significantly	correlated	with	increased	potassium	levels	(C)	and	decreased	sodium	levels	(D);	P = .01 
and P = 0.008,	respectively





































































































Physiologically,	 the	 liver	serves	as	a	buffer	 for	enteral	potas‐
sium	 loads.	 Cellular	 potassium	 uptake	 requires	 active	 transport	
by	 the	 ATP‐dependent	 Na+/K+‐ATPase.4,17	 Low	 temperatures	
(8‐12	degrees	Celsius)	during	DHOPE	are	likely	to	impair	optimal	
function	of	Na+/K+‐ATPase,	thereby	facilitating	passive	potassium	
release.18	 The	 total	 mean	 hepatic	 release	 of	 potassium	 during	
DHOPE	 varied	 from	 17	mmol	 in	 preclinical	 livers	 to	 34	mmol	
clinical	 livers	 (Figure	5).	Also,	as	a	consequence	of	 impaired	Na+/
K+‐ATPase	during	DHOPE,	the	total	mean	hepatic	sodium	uptake	
was	25	 to	29	mmol	 in	preclinical	 and	clinical	 livers,	 respectively.	
Moreover,	in	line	with	previously	published	data,	cellular	ATP	lev‐
els	were	significantly	higher	in	DHOPE	preserved	livers	compared	
to	 controls	 upon	 ex	 situ	 reperfusion.13	 Furthermore,	 this	 study	
showed	 that	 high	 ATP	 levels	 upon	 reperfusion	 significantly	 cor‐
related	with	 decreased	 potassium.	 This	 underlines	 the	 potential	
role	of	the	ATP	dependent	hepatic	potassium	uptake	in	DHOPE‐
preserved	 livers.	 Moreover,	 in	 both	 our	 preclinical	 and	 clinical	
study,	 increased	potassium	 levels	 correlated	with	high	peak	ALT	
levels	upon	reperfusion.	In	other	words,	a	decrease	in	potassium	
levels	 upon	 reperfusion	might	 therefore	 be	 an	 interesting	 “early	
prediction”	marker	of	good	liver	function.	However,	future	studies	





potassium	 levels	 after	 reperfusion	 of	 UW‐preserved	 liver	 grafts	
compared	 to	histidine‐tryptophan‐ketoglutarate	 solution	 in	 adult	
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living	donor	liver	transplantations.19	It	must	be	noted	that,	due	to	
logistical	 differences	 between	 postmortal	 and	 living	 donor	 liver	
transplantations,	 cold	 ischemia	 times	 (mean	 66	minutes)	 in	 this	
study	were	 substantially	 shorter	 than	 cold	 ischemia	 times	 in	our	
study	groups.	In	pediatric	liver	transplantation,	hypokalemia	after	
graft	 reperfusion	 is	more	commonly	 seen.	The	underlying	mech‐
anism	has	yet	to	be	elucidated.20	Both	 living	donor	and	pediatric	
liver	 transplant	 procedures	 can,	 however,	 not	 be	 compared	with	
our	patient	group.
The	 first	 clinical	 series	 of	 oxygenated	 hypothermic	 machine	
perfusion did not report potassium or sodium concentrations.21 
However,	Guarrera	et	al	published	the	first	clinical	series	of	 trans‐
plantation	of	nonoxygenated	hypothermic	machine	perfused	(HMP)	
liver	 grafts.7	 These	 authors	 used	 a	 perfusion	 solution	 with	 the	
same	potassium	content	as	Belzer‐UW	machine	perfusion	solution	


















an	 increase	 in	 blood	 potassium	 concentration	 after	 graft	 reperfu‐
sion.	Current	preemptive	anti‐hyperkalemic	measures,	 such	as	 the	
use	of	glucose/insulin	and	sodium	bicarbonate,	might	aggravate	the	







Another	 clinical	 challenge	 that	 anesthesiologists	 may	 encoun‐
ter	during	graft	 reperfusion	 is	 hemodynamic	 instability.	While	 the	







groups	with	adequate	 increase	 in	 the	noradrenaline	dose.	We	did,	
however,	observe	that	increased	noradrenaline	requirements	upon	
reperfusion	 correlated	 with	 increased	 potassium	 levels	 and	 de‐
creased	sodium	levels.	It	has	to	be	noted	that	data	on	MAP	and	ino‐
tropic	doses	were	not	complete	in	two	out	of	nine	control	patients.
The	decrease	 instead	of	 increase	 in	blood	potassium	concen‐
tration	 after	 reperfusion	 of	 a	DHOPE‐preserved	 liver	 graft	may	
actually	 be	 helpful	 in	 patients	 with	 concomitant	 renal	 insuffi‐
ciency.	Many	patients	with	end‐stage	liver	disease	also	have	some	
degree	of	 renal	 failure,	making	 them	more	 prone	 for	 difficult	 to	
control	hyperkalemia.	The	increase	in	blood	potassium	concentra‐
tions	after	 reperfusion	of	a	SCS‐preserved	 liver	graft	may	cause	
cardiovascular	 instability	 due	 to	 arrhythmias	 in	 these	 patients	
and	 this	 problem	 should	 be	 less	 frequent	 after	 reperfusion	 of	 a	
DHOPE‐preserved	liver.
In	 conclusion,	 while	 hyperkalemia	 is	 generally	 anticipated	
during	transplantation	of	a	SCS‐preserved	 liver,	 reperfusion	of	a	
DHOPE‐preserved	 liver	 is	 associated	 with	 potassium	 uptake	 by	
the	 liver,	which	 can	 lead	 to	 a	 decrease	 in	 blood	 potassium	 con‐
centrations	 or	 even	 hypokalemia.	Anesthesiologists	 and	 surgical	
teams	 should	 be	 prepared	 for	 this	 opposite	 shift	 in	 potassium	
during	transplantation.
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